Language of the Report - English
ومع ذلك، قد يكون التقرير متوفرًا بالعربية مقابل تكلفة إضافية.
1 Preface
2 Scope and Methodology
2.1 Objectives of the Study
2.2 Stakeholders
2.3 Data Sources
2.3.1 Primary Sources
2.3.2 Secondary Sources
2.4 Market Estimation
2.4.1 Bottom-Up Approach
2.4.2 Top-Down Approach
2.5 Forecasting Methodology
3 Executive Summary
4 Introduction
4.1 Overview
4.2 Key Industry Trends
5 Global Generic Drug Market
5.1 Market Overview
5.2 Market Performance
5.3 Market Breakup by Region
5.4 Market Forecast
5.5 Major Players
6 Global Generic Drug Delivery Market
6.1 Oral
6.2 Injectables
6.3 Dermal/Topical
6.4 Inhalers
7 Global Generic Injectables Market
7.1 Market Overview
7.2 Market Performance
7.3 Impact of COVID-19
7.4 Market Breakup by Region
7.5 Market Breakup by Therapeutic Area
7.6 Market Breakup by Container
7.7 Market Breakup by Distribution Channel
7.8 Market Forecast
7.9 SWOT Analysis
7.9.1 Overview
7.9.2 Strengths
7.9.3 Weaknesses
7.9.4 Opportunities
7.9.5 Threats
7.10 Value Chain Analysis
7.11 Porter’s Five Forces Analysis
7.11.1 Overview
7.11.2 Bargaining Power of Buyers
7.11.3 Bargaining Power of Suppliers
7.11.4 Degree of Competition
7.11.5 Threat of New Entrants
7.11.6 Threat of Substitutes
7.12 Key Market Drivers and Success Factors
8 Global Generic Injectables Market: Performance of Key Regions
8.1 North America
8.1.1 Market Trends
8.1.2 Market Forecast
8.2 Europe
8.2.1 Market Trends
8.2.2 Market Forecast
8.3 Asia
8.3.1 Market Trends
8.3.2 Market Forecast
8.4 Latin America
8.4.1 Market Trends
8.4.2 Market Forecast
8.5 Middle East and Africa
8.5.1 Market Trends
8.5.2 Market Forecast
9 Market by Therapeutic Area
9.1 Oncology
9.1.1 Market Trends
9.1.2 Market Forecast
9.2 Anaesthesia
9.2.1 Market Trends
9.2.2 Market Forecast
9.3 Anti-infectives
9.3.1 Market Trends
9.3.2 Market Forecast
9.4 Parenteral Nutrition
9.4.1 Market Trends
9.4.2 Market Forecast
9.5 Cardiovascular
9.5.1 Market Trends
9.5.2 Market Forecast
10 Market by Container
10.1 Vials
10.1.1 Market Trends
10.1.2 Market Forecast
10.2 Ampoules
10.2.1 Market Trends
10.2.2 Market Forecast
10.3 Premix
10.3.1 Market Trends
10.3.2 Market Forecast
10.4 Prefilled Syringes
10.4.1 Market Trends
10.4.2 Market Forecast
11 Market by Distribution Channel
11.1 Hospitals
11.1.1 Market Trends
11.1.2 Market Forecast
11.2 Retail Pharmacy
11.2.1 Market Trends
11.2.2 Market Forecast
12 Global Generic Injectables Market: Competitive Landscape
12.1 Market Structure
12.2 Market Breakup by Key Players
13 Generic Injectables Manufacturing Process
13.1 Product Overview
13.2 Detailed Process Flow (Injectables)
13.3 Various Types of Unit Operations Involved
13.4 Mass Balance and Raw Material Requirements
14 Project Details, Requirements and Costs Involved
14.1 Land Requirements and Expenditures
14.2 Construction Requirements and Expenditures
14.3 Plant Machinery
14.4 Machinery Pictures
14.5 Raw Material Requirements and Expenditures
14.6 Packaging Requirements and Expenditures
14.7 Transportation Requirements and Expenditures
14.8 Utility Requirements and Expenditures
14.9 Manpower Requirements and Expenditures
14.10 Other Capital Investments
15 Loans and Financial Assistance
16 Project Economics
16.1 Capital Cost of the Project
16.2 Techno-Economic Parameters
16.3 Product Pricing and Margins Across Various Levels of the Supply Chain
16.4 Taxation and Depreciation
16.5 Income Projections
16.6 Expenditure Projections
16.7 Financial Analysis
16.8 Profit Analysis
17 Key Player Profiles
17.1 Baxter International Inc.
17.1.1 Company Overview
17.1.2 Product Portfolio
17.1.3 Financials
17.1.4 SWOT Analysis
17.2 Fresenius Kabi AG
17.2.1 Company Overview
17.2.2 Product Portfolio
17.2.3 Financials
17.2.4 SWOT Analysis
17.3 Hikma Pharmaceuticals plc
17.3.1 Company Overview
17.3.2 Product Portfolio
17.3.3 Financials
17.3.4 SWOT Analysis
17.4 Pfizer Inc.
17.4.1 Company Overview
17.4.2 Product Portfolio
17.4.3 Financials
17.4.4 SWOT Analysis
17.5 Sagent Pharmaceuticals Inc. (Nichi-Iko Pharmaceutical Co. Ltd.)
17.5.1 Company Overview
17.5.2 Product Portfolio
17.5.3 Financials
17.5.4 SWOT Analysis
17.6 Sandoz International GmbH (Novartis International AG)
17.6.1 Company Overview
17.6.2 Product Portfolio
17.6.3 Financials
17.6.4 SWOT Analysis
17.7 Sanofi S.A.
17.7.1 Company Overview
17.7.2 Product Portfolio
17.7.3 Financials
17.7.4 SWOT Analysis
List of Figures
Figure 1: Global: Generic Drug Market: Value Trends (in Billion US$), 2017-2022
Figure 2: Global: Generic Drug Market: Breakup by Region (in %), 2022
Figure 3: Global: Generic Drug Market Forecast: Value Trends (in Billion US$), 2023-2028
Figure 4: Global: Generic Drug Delivery Market: Oral (in Million US$), 2017, 2022 & 2028
Figure 5: Global: Generic Drug Delivery Market: Injectables (in Million US$), 2017, 2022 & 2028
Figure 6: Global: Generic Drug Delivery Market: Dermal/Topical (in Million US$), 2017, 2022 & 2028
Figure 7: Global: Generic Drug Delivery Market: Inhalers (in Million US$), 2017, 2022 & 2028
Figure 8: Global: Generic Injectables Market: Value Trends (in Billion US$), 2017-2022
Figure 9: Global: Generic Injectables Market: Breakup by Region (in %), 2022
Figure 10: Global: Generic Injectables Market: Breakup by Therapeutic Area (in %), 2022
Figure 11: Global: Generic Injectables Market: Breakup by Container (in %), 2022
Figure 12: Global: Generic Injectables Market: Breakup by Distribution Channel (in %), 2022
Figure 13: Global: Generic Injectables Market Forecast: Value Trends (in Billion US$), 2023-2028
Figure 14: Global: Generic Injectables Industry: SWOT Analysis
Figure 15: Global: Generic Injectables Industry: Value Chain Analysis
Figure 16: Global: Generic Injectables Industry: Porter’s Five Forces Analysis
Figure 17: North America: Generic Injectables Market (in Million US$), 2017 & 2022
Figure 18: North America: Generic Injectables Market Forecast (in Million US$), 2023-2028
Figure 19: Europe: Generic Injectables Market (in Million US$), 2017 & 2022
Figure 20: Europe: Generic Injectables Market Forecast (in Million US$), 2023-2028
Figure 21: Asia: Generic Injectables Market (in Million US$), 2017 & 2022
Figure 22: Asia: Generic Injectables Market Forecast (in Million US$), 2023-2028
Figure 23: Latin America: Generic Injectables Market (in Million US$), 2017 & 2022
Figure 24: Latin America: Generic Injectables Market Forecast (in Million US$), 2023-2028
Figure 25: Middle East and Africa: Generic Injectables Market (in Million US$), 2017 & 2022
Figure 26: Middle East and Africa: Generic Injectables Market Forecast (in Million US$), 2023-2028
Figure 27: Global: Generic Injectables (Oncology) Market: Value Trends (in Million US$), 2017 & 2022
Figure 28: Global: Generic Injectables (Oncology) Market Forecast: Value Trends (in Million US$), 2023-2028
Figure 29: Global: Generic Injectables (Anaesthesia) Market: Value Trends (in Million US$), 2017 & 2022
Figure 30: Global: Generic Injectables (Anaesthesia) Market Forecast: Value Trends (in Million US$), 2023-2028
Figure 31: Global: Generic Injectables (Anti-infectives) Market: Value Trends (in Million US$), 2017 & 2022
Figure 32: Global: Generic Injectables (Anti-infectives) Market Forecast: Value Trends (in Million US$), 2023-2028
Figure 33: Global: Generic Injectables (Parenteral Nutrition) Market: Value Trends (in Million US$), 2017 & 2022
Figure 34: Global: Generic Injectables (Parenteral Nutrition) Market Forecast: Value Trends (in Million US$), 2023-2028
Figure 35: Global: Generic Injectables (Cardiovascular) Market: Value Trends (in Million US$), 2017 & 2022
Figure 36: Global: Generic Injectables (Cardiovascular) Market Forecast: Value Trends (in Million US$), 2023-2028
Figure 37: Global: Generic Injectables (Vials) Market: Value Trends (in Million US$), 2017 & 2022
Figure 38: Global: Generic Injectables (Vials) Market Forecast: Value Trends (in Million US$), 2023-2028
Figure 39: Global: Generic Injectables (Ampoules) Market: Value Trends (in Million US$), 2017 & 2022
Figure 40: Global: Generic Injectables (Ampoules) Market Forecast: Value Trends (in Million US$), 2023-2028
Figure 41: Global: Generic Injectables (Premix) Market: Value Trends (in Million US$), 2017 & 2022
Figure 42: Global: Generic Injectables (Premix) Market Forecast: Value Trends (in Million US$), 2023-2028
Figure 43: Global: Generic Injectables (Prefilled Syringes) Market: Value Trends (in Million US$), 2017 & 2022
Figure 44: Global: Generic Injectables (Prefilled Syringes) Market Forecast: Value Trends (in Million US$), 2023-2028
Figure 45: Global: Generic Injectables Market: Sales through Hospitals (in Million US$), 2017 & 2022
Figure 46: Global: Generic Injectables Market Forecast: Sales through Hospitals (in Million US$), 2023-2028
Figure 47: Global: Generic Injectables Market: Sales through Retail Pharmacy (in Million US$), 2017 & 2022
Figure 48: Global: Generic Injectables Market Forecast: Sales through Retail Pharmacy (in Million US$), 2023-2028
Figure 49: Generic Injectables Manufacturing Process: Conversion Rate of Feedstocks
Figure 50: Generic Injectables Manufacturing: Detailed Process Flow
Figure 51: Generic Injectables Manufacturing: Production Cost Breakup (in %)
Figure 52: Generic Injectables Industry: Profit Margins at Various Levels of the Supply Chain
Figure 53: Generic Injectables Manufacturing Plant: Proposed Plant Layout
Figure 54: Generic Injectables Manufacturing Plant: Breakup of Capital Costs (in %)
List of Tables
Table 1: Global: Generic Drug Market: Key Industry Highlights, 2022 and 2028
Table 2: Global: Generic Drug Market Forecast: Breakup by Region, 2023-2028
Table 3: Global: Generic Drug Market: Revenues of Key Players (in Million US$), 2019
Table 4: Global: Generic Injectables Market: Key Industry Highlights, 2022 and 2028
Table 5: Global: Generic Injectables Market Forecast: Breakup by Region (in Million US$), 2023-2028
Table 6: Global: Generic Injectables Market Forecast: Breakup by Therapeutic Area (in Million US$), 2023-2028
Table 7: Global: Generic Injectables Market Forecast: Breakup by Container (in Million US$), 2023-2028
Table 8: Global: Generic Injectables Market Forecast: Breakup by Distribution Channel (in Million US$), 2023-2028
Table 9: Generic Injectables Manufacturing Plant: Costs Related to Land and Site Development (in US$)
Table 10: Generic Injectables Manufacturing Plant: Costs Related to Civil Works (in US$)
Table 11: Generic Injectables Manufacturing Plant: Costs Related to Machinery Unit (in US$)
Table 12: Generic Injectables Manufacturing Plant: Raw Material Requirements (Kg/Day) and Expenditures (US$/Kg)
Table 13: Generic Injectables Manufacturing Plant: Costs Related to Salaries and Wages (in US$)
Table 14: Generic Injectables Manufacturing Plant: Costs Related to Other Capital Investments (in US$)
Table 15: Details of Financial Assistance Offered by Financial Institutions
Table 16: Generic Injectables Manufacturing Plant: Capital Costs (in US$)
Table 17: Generic Injectables Manufacturing Plant: Techno-Economic Parameters (in US$)
Table 18: Generic Injectables Manufacturing Plant: Taxation and Depreciation (in US$)
Table 19: Generic Injectables Manufacturing Plant: Income Projections (in US$)
Table 20: Generic Injectables Manufacturing Plant: Expenditure Projections (in US$)
Table 21: Generic Injectables Manufacturing Plant: Cash Flow Analysis Without Considering the Income Tax Liability (in US$)
Table 22: Generic Injectables Manufacturing Plant: Cash Flow Analysis on Considering the Income Tax Liability (in US$)
Table 23: Generic Injectables Manufacturing Plant: Profit and Loss Account (in US$)